In the January issue of Fertility and Sterility a Bostonbased group of investigators (Abussief et al., Fertil Steril 2007; 87:88-92) reported that a considerable majority of academic and privately owned IVF centers do not follow advertising guidelines of the Society for Assisted Reproductive Technology (SART) and American Society for Reproductive Medicine (ASRM). Adherence to these guidelines is a precondition for SART membership.
A total of 289 SART-affiliated IVF centers with life websites, amongst those 78 academic and 211 private, were investigated by the researchers. The results were almost equally bad for private and academic IVF programs. Amongst programs that published IVF success rates (and approximately half did), only a minority complied with the published advertising guidelines, which mandate that clinical pregnancy rates be specifically described, referring to cycle start, oocyte retrieval or embryo transfer as denominator. Indeed, academic centers did even worse than private IVF programs; Only 22 percent of academic, and 36 of private, centers complied with SART/ASRM guidelines.
When it came to outright advertisement, private centers were more aggressive than their academic counterparts. They were significantly more likely to advertise special services, such as oocyte donation, oocyte cryopreservation, preimplantation genetic diagnosis and gender selection. They also more frequently offered financial incentives like "shared risk" plans or "100 percent money-back guarantees."
Inappropriate representations not only endanger a program's SART membership. Misrepresentations of a program's IVF success rates can also lead to audits and penalties from the Federal Trade Commission. Everybody better watch their websites!
The joys of sweating
Sweating may be better for you than you thought; -that is, if you are a male, striving for female company. Investigators from California, and the Weizmann Institute in Israel, recently reported in the Journal of Neuroscience that androstadienone (4,16-androstadien-3-one), a compound in male perspiration, eludes an alluring scent that can effect physiologic responses of heterosexual women. When sniffing from a bottle, containing androstadienone, 48 study subject were noted to be affected in mood, brain activity and degree of sexual arousal (J Neuroscience 2007; 27:1261-5) .
In the introduction to their paper the authors note that in certain animals species chemosignals have been known to alter endocrine balances. This study now points towards a similar potential role for synthetic human chemosignals in clinical applications.
These findings, as so often is the case in science, allow for collateral conclusions: One offers a potentially clearer understanding of the attraction of health clubs, and another, of course, resurrects the discussion surrounding the wisdom of older rules in professional sports, which restricted the access of female reporters to male locker rooms. If confirmed by further investigations, the future seems obvious now: The recreational phrase of the future will be, "here baby, have a sniff!"
How nature battles promiscuity
Two recent studies, involving animal experimentation, shed light on how nature deals with promiscuity. In a first study in rodents, a group of scientists from the University of Sheffield (UK) report that sperm from promiscuous rodents somehow acquire the ability to work together to beat out sperm from rival males (Immler et al., PloS ONE 2007; 2:e170) . The investigators noted in their paper that spermatozoa, usually operating independently in fierce competition, start cooperating with each other in a unified attempt at reaching the female's eggs first, if they find themselves up against competition from spermatozoa from another male.
In another study from the UK, investigators reported that female promiscuity and sexual fatigue of males increase in certain insects if male-killing bacteria reduce the number of males available for mating (Charlat S, et al., Curr Biol 2007; 17:273-7) . Males produce smaller sperm packages and females become more rampant, apparently sensing the lowered chance of conception per encounter. In the insect species investigated the male to female ratio, after malekilling bacteria had done their job, was as low as one male for every few hundred females.
These animal data, of course, raise questions about extrapolations to the human experience. Since humans are neither rodents, nor insects, such extrapolations are not really possible without appropriate studies in humans. Considering the number of potential claimants of paternity to Anna Nicole's daughter, she would have been ideal as a study subject, addressing the first issue. In reference to the second study, answers may be easier to come by: If current population trends in China and India, which have created considerable surpluses of males, were to continue, it should not be too difficult to determine whether long-term effects on sexual behavior would become apparent. Extrapolating from the insect experience, and inverting it, males should become more promiscuous and females more fatigued. Let's wait and see!
Umbilical cord blood banking
In a recent editorial The Lancet applauded Virgin's Richard Branson in establishing yet another business venture with a remarkable degree of social responsibility (Editorial 2007; 369:437) . The new Branson enterprise, Virgin Health Bank, is an umbilical cord blood storage facility, which allows parents for GB£1,500 to buy storage for a 20-year period. However, like with most of his enterprises, there is a twist to the story: Only a fifth of the cord blood sample will be stored for private use, while the rest will be donated to a public part of the umbilical cord bank, accessible to anybody in need, -world wide. In addition, he will donate one half of the bank's profits to initiatives, which will realize the therapeutic potential of cord blood stem cells.
In a somewhat surprising comment, the usually politically rather left-leaning Lancet supported Branson's attempt at combining commercial self-interest with altruism and, indeed, contrasts his approach favorably to the unresponsiveness of the UK's (socialized) National Health System. It is nice to see The Lancet, for once, supporting market-driven health care. Maybe, one day their editors will also stop attacking U.S., and Israeli, foreign and security policies!
